GEN - Genetic Engineering and Biotechnology News

Baylor College of Medicine Taps Nautilus’ Voyager for Cancer Proteomics

Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit• NIH-funded project leverages ...

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare ...

Detailed price information for Pharmala Biotech Holdings Inc. (MDMA-CN) from The Globe and Mail including charting and trades.

Nautilus Energizes New Markets, Strengthens Grid, and Deepens Community Investment in 2025

CHICAGO, IL, March 16, 2026 (GLOBE NEWSWIRE) -- Nautilus Solar Energy (Nautilus) reached a milestone year in 2025 marked by historic growth, expanded clean energy generation, and deepened investment ...
The Pharma Letter

Nautilus names Amber Faust VP of sales

Seattle-based Nautilus Biotechnology, a specialist in single-molecule proteome analysis, has announced the appointment of Amber Faust as vice president of sales.
Taiwan News

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

SEATTLE, March 02, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice ...
manilatimes

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform SEATTLE, March 02, 2026 ...